AI and multimodal data are driving a shift toward N-of-1 medicine, tailoring interventions to a person's unique biological ...
Scientists are exploring DNA-based robots, tiny molecular machines that could one day navigate the body, deliver targeted therapies, and even build nanoscale technologies.
Researchers developed a chip-based platform, “μPharma,” that rapidly predicts drug response through AI analysis for children ...
The building blocks of proteins, amino acids, are essential for all living things. Twenty different amino acids build the ...
Mass spectrometry unveils a world of proteins, from those in cells to fragments found on fossils, as well as the small ...
This Research Topic is the second volume of the “Unraveling Breast Cancer Complexity: Insights from Single-Cell Sequencing and Spatial Transcriptomics” ...
One dog, one vaccine, one data point. The story of Rosie is fascinating – but it is not yet evidence that AI can beat cancer.
Genovis AB, a leading provider of innovative enzyme technologies, today announces a strategic partnership with Single Cell Discoveries to broaden the application of the SEQURNA® Thermostable RNase Inh ...
Forlong Biotechnology, a clinical-stage biotech company focusing on developing transformative cytokine therapies for patients with severe unmet needs, today announced that preclinical data from its IL ...
Increasing the efficiency of LNPs as therapeutic vehicles offers promise for better mRNA-based and gene editing treatment ...
Researchers discovered immune cell aggregates in the gut may signal blood vessel cells and fibroblasts to produce excess ...
Researchers at the Earlham Institute, the University of Edinburgh and Heriot-Watt University analyzed gut cells to understand ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results